MFDS — authorised 13 July 1984
- Marketing authorisation holder: BRAINTREE
- Status: likely_approved
🇰🇷 Miralax in South Korea
MFDS authorised Miralax on 13 July 1984
Marketing authorisation
Miralax in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Ophthalmology approved in South Korea
Frequently asked questions
Is Miralax approved in South Korea?
Yes. MFDS authorised it on 13 July 1984.
Who is the marketing authorisation holder for Miralax in South Korea?
BRAINTREE holds the South Korean marketing authorisation.